The template agreements for the Tissue Chip for Drug Screening program are available here. They are designed to streamline the legal and administrative process for partnering across multiple organizations. The agreements save time and effort, and they provide a roadmap for handling intellectual property used in or developed through the program.
Memorandum of Understanding (MOU)
- MOU between NCATS and and the IQ Consortium for the Coordinated Microphysiological Systems for Drug Efficacy and Toxicity Testing in Human Health and Disease (PDF - 110KB)
- MOU between NCATS and CASIS for the Coordinated Tissue Chip Systems for Drug Efficacy and Toxicity Testing in Human Health and Disease (PDF - 52KB)
Confidential Disclosure Agreements (CDAs)
- Tissue Chip Testing Center CDA (PDF - 26KB}
- Tissue Chips in Space CDA: